NTA_AVIPU
ID NTA_AVIPU Reviewed; 36 AA.
AC P0DQJ6;
DT 11-DEC-2019, integrated into UniProtKB/Swiss-Prot.
DT 11-DEC-2019, sequence version 1.
DT 25-MAY-2022, entry version 7.
DE RecName: Full=Mu/kappa-theraphotoxin-Ap1a {ECO:0000303|PubMed:30149017};
DE Short=Mu/kappa-TRTX-Ap1a {ECO:0000303|PubMed:30149017};
DE AltName: Full=Avicularia purpurea;
OS Avicularia purpurea (Ecuadorian purple pinktoe tarantula).
OC Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida; Araneae;
OC Mygalomorphae; Theraphosidae; Avicularia.
OX NCBI_TaxID=2652666;
RN [1]
RP PROTEIN SEQUENCE, FUNCTION, SYNTHESIS, AMIDATION AT PHE-36, SUBCELLULAR
RP LOCATION, MASS SPECTROMETRY, AND PHARMACEUTICAL.
RC TISSUE=Venom;
RX PubMed=30149017; DOI=10.1016/j.bcp.2018.08.038;
RA Ma L., Chin Y.K.Y., Dekan Z., Herzig V., Chow C.Y., Heighway J., Lam S.W.,
RA Guillemin G.J., Alewood P.F., King G.F.;
RT "Novel venom-derived inhibitors of the human EAG channel, a putative
RT antiepileptic drug target.";
RL Biochem. Pharmacol. 158:60-72(2018).
CC -!- FUNCTION: Inhibitor of voltage-gated potassium and sodium channels.
CC Among other potassium channels, it selectively inhibits
CC Kv10.1/KCNH1/EAG1 (IC(50)=236 nM) by shifting the voltage dependence of
CC channel activation in a depolarising direction, it shows a maximum
CC inhibition of 80% at saturating concentrations, it shows fast on-rates,
CC and is poorly reversible. It also slightly affects channel
CC inactivation, when the membrane is highly depolarised (>+80 mV). It
CC shows similar potency on Nav1.7/SCN9A (IC(50)=222 nM) and lower potency
CC on Nav1.2/SCN2A (IC(50)=519 nM). {ECO:0000269|PubMed:30149017}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:30149017}.
CC -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC {ECO:0000305|PubMed:30149017}.
CC -!- DOMAIN: The presence of a 'disulfide through disulfide knot'
CC structurally defines this protein as a knottin.
CC {ECO:0000305|PubMed:30149017}.
CC -!- MASS SPECTROMETRY: Mass=4220.077; Method=MALDI; Note=Monoisotopic
CC mass.; Evidence={ECO:0000269|PubMed:30149017};
CC -!- PHARMACEUTICAL: Could be used as informative lead for the development
CC of novel antiepileptic drugs, as well as pharmacological tool for
CC probing Kv10.1/KCNH1/EAG1 function. {ECO:0000305|PubMed:30149017}.
CC -!- MISCELLANEOUS: Weakly inhibits Nav1.5/SCN5A (IC(50)=2565), and
CC Kv11.1/KCNH2/ERG1 (IC(50)=8197 nM). {ECO:0000269|PubMed:30149017}.
CC -!- SIMILARITY: Belongs to the neurotoxin 10 (Hwtx-1) family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR AlphaFoldDB; P0DQJ6; -.
DR SMR; P0DQJ6; -.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0008200; F:ion channel inhibitor activity; IEA:InterPro.
DR GO; GO:0015459; F:potassium channel regulator activity; IEA:UniProtKB-KW.
DR GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR InterPro; IPR011696; Huwentoxin-1.
DR Pfam; PF07740; Toxin_12; 1.
PE 1: Evidence at protein level;
KW Amidation; Direct protein sequencing; Disulfide bond;
KW Ion channel impairing toxin; Knottin; Pharmaceutical;
KW Potassium channel impairing toxin; Secreted; Toxin;
KW Voltage-gated potassium channel impairing toxin.
FT CHAIN 1..36
FT /note="Mu/kappa-theraphotoxin-Ap1a"
FT /evidence="ECO:0000269|PubMed:30149017"
FT /id="PRO_0000448841"
FT MOD_RES 36
FT /note="Phenylalanine amide"
FT /evidence="ECO:0000269|PubMed:30149017"
FT DISULFID 3..18
FT /evidence="ECO:0000250|UniProtKB:A0A3F2YLP5"
FT DISULFID 10..23
FT /evidence="ECO:0000250|UniProtKB:A0A3F2YLP5"
FT DISULFID 17..30
FT /evidence="ECO:0000250|UniProtKB:A0A3F2YLP5"
SQ SEQUENCE 36 AA; 4230 MW; A4240EFB7F4DCB2E CRC64;
GDCHKFWGWC RDEPDPCCEH LTCSTKHGWC VWDGSF